Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Impact of the pandemic on various infectious diseases with different epidemiological patterns of seasonality, transmission and age].
Gascó-Laborda JC, Tirado-Balaguer MD, Gil-Fortuño M, Dorina Deaconescu G, Sabalza-Baztán O, Pérez-Olaso Ó, Gómez-Alfaro I, Hernández-Pérez N, Bellido-Blasco JB. Gascó-Laborda JC, et al. Among authors: gomez alfaro i. Rev Esp Salud Publica. 2024 Feb 21;98:e202402011. Rev Esp Salud Publica. 2024. PMID: 38385502 Spanish.
Association of nirmatrelvir/ritonavir and remdesivir as treatment for SARS-CoV-2 infection in immunocompromised patients with hematologic malignancies. Series of four cases.
Segura Fábrega A, Pérez Catalán I, Gómez Alfaro I, García Muñoz S, Roig Martí C, Rodríguez Lozano N, Folgado Escudero S, Varea Villanueva M, Gascón Buj A, Torres García M, Reig Valero R, Ferrando Piqueres R, Usó Blasco J. Segura Fábrega A, et al. Among authors: gomez alfaro i. Rev Esp Quimioter. 2023 Dec;36(6):655-657. doi: 10.37201/req/069.2023. Epub 2023 Oct 3. Rev Esp Quimioter. 2023. PMID: 37786958 Free PMC article. English.
Nirmatrelvir/ritonavir as a possible treatment for Long-COVID.
Pérez Catalán I, Gascón Buj A, García Muñoz S, Gómez Alfaro I, Roig Martí C, Torres García M, Reig Valero R, Ferrando Piqueres R, Mateu Campos L, Ramos Rincón JM, Usó Blasco J. Pérez Catalán I, et al. Among authors: gomez alfaro i. Rev Esp Quimioter. 2023 Oct;36(5):545-546. doi: 10.37201/req/028.2023. Epub 2023 Jun 27. Rev Esp Quimioter. 2023. PMID: 37357766 Free PMC article. No abstract available.
Antiviral treatment or mAbs for persistent SARS-COV-2 infection in patients with hematologic malignancies: A case series.
Pérez-Catalán I, Gómez-Alfaro I, García-Muñoz S, Roig-Martí C, Rodríguez-Lozano N, Fabra-Juana S, Esteve-Gimeno MJ, Gascón-Buj A, Freiria-Alberte C, Clavel-Pia J, Torres-García M, Reig-Valero R, Ferrando-Piqueres R, Mateu-Campos L, Usó-Blasco J, Ramos-Rincón JM. Pérez-Catalán I, et al. Among authors: gomez alfaro i. J Med Virol. 2023 Jun;95(6):e28865. doi: 10.1002/jmv.28865. J Med Virol. 2023. PMID: 37314151 No abstract available.
Nirmatrelvir/ritonavir as a potential treatment for prolonged SARS-CoV-2 infection in immunocompromised patients.
Pérez Catalán I, García Muñoz S, Roig Martí C, Gómez Alfaro I, Serrano Picazo L, Torres García M, Reig Valero R, Ferrando Piqueres R, Mateu Campos L, Ramos Rincón JM, Usó Blasco J. Pérez Catalán I, et al. Among authors: gomez alfaro i. Rev Esp Quimioter. 2022 Dec;35(6):589-591. doi: 10.37201/req/078.2022. Epub 2022 Oct 18. Rev Esp Quimioter. 2022. PMID: 36250675 Free PMC article. No abstract available.